51
Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON SETTINGS IN ESTONIA, LATVIA AND LITHUANIA

Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Presented by Roger Drew

Riga29th January 2009

Findings of Mid-Term Evaluation

HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

SETTINGS IN ESTONIA, LATVIA AND LITHUANIA

Page 2: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Baltic countries have significant HIV epidemics

� HIV continues to spread mainly through injecting drug use

� There are relatively high HIV prevalence rates in Baltic prisons

Introduction

Page 3: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Four year project started in 2006

� $5m

� From Dutch government

� Managed by UNODC project office in Vilnius

Background

Page 4: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� To learn lessons from project implementation to improve future project planning, design and management

Purpose of Evaluation

Page 5: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Review of available literature

� Semi-structured interviews with key informants during three country visits

� … and also with a few regional/international bodies and international experts

� Limitations

Method

Page 6: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 7: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 8: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Fit with UNAIDS Division of Labour

� Convening power of UN agency

� Credibility with criminal justice system

� Approach

� Collaborative

� Neutral, professional and evidence-based

� Long-term, diplomatic, incremental, persuasive

� Flexible and country-driven approach to financing

UNODC Priority and Comparative Advantage

Page 9: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 10: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Highly relevant

� Difficulties of working on HIV and AIDS in prison system

Objectives: Relevance and Attainability

Page 11: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 12: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Growing consensus on importance of harm reduction approaches

� Increasing coverage… but need for agreed measures

� Increasing availability of strategic information

� Strong focus on capacity building activities

� Support to development of new national programmes in Latvia and Lithuania

Progress towards Objectives and Results

Page 13: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 14: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Yes… because of relevance of objectives

Usefulness of Results

Page 15: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 16: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� On HIV transmission…

� But issues of attribution

� Differences between countries

Likely Impact

Page 17: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 18: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Government responsibility

� Political commitment

� Coordination function

� Financing mechanisms

� Risks

� Advocacy

� NGO capacity and fundraising

Sustainability

Page 19: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Government responsibility

� Political commitment

� Coordination function

� Financing mechanisms

� Risks

� Advocacy

� NGO capacity and fundraising

Sustainability

Page 20: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Political Commitment

Environment for harm red (prisons)

Environment for harm red (comm)

Focus based on epidemiology

National coordination capacity

National coordination mechanism

Roles and responsibilities defined

Financing

Political continuity

Recognition as political priority

Page 21: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Government responsibility

� Political commitment

� Coordination function

� Financing mechanisms

� Risks

� Advocacy

� NGO capacity and fundraising

Sustainability

Page 22: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Government responsibility

� Political commitment

� Coordination function

� Financing mechanisms

� Risks

� Advocacy

� NGO capacity and fundraising

Sustainability

Page 23: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Funding Mechanisms

Level 4: In addition to levels 1-3, funding flows

through identified sustainable mechanism

Level 3: In addition to levels 1-2, sustainable funder is involved in project management and supervision

Level 2: In addition to level 1, sustainable funder

gives in-principle commitment to continue funding activities

Level 1: Sustainable source of future funding clearly

identified and agreed

Page 24: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Government responsibility

� Political commitment

� Coordination function

� Financing mechanisms

� Risks

� Advocacy

� NGO capacity and fundraising

Sustainability

Page 25: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Risks

NGO services

Prisons

Low Threshold Centres

MMT

Page 26: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Government responsibility

� Political commitment

� Coordination function

� Financing mechanisms

� Risks

� Advocacy

� NGO capacity and fundraising

Sustainability

Page 27: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 28: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Adverse economic environment

� Prison settings

� Capacity issues in small countries

� Also country-specific issues

Problems and Constraints

Page 29: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 30: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Initial project implementation

� Management structures

� M&E framework

� Staffing levels

� Flow of information

� Financial management

� UN coordination

Planning, Implementation and Management

Page 31: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Initial project implementation

� Management structures

� M&E framework

� Staffing levels

� Flow of information

� Financial management

� UN coordination

Planning, Implementation and Management

Page 32: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Initial Project Implementation

0

200000

400000

600000

800000

1000000

1200000

1400000

2006 2007 2008 2009 2010

$

Budget Expenditure

Page 33: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Initial project implementation

� Management structures

� M&E framework

� Staffing levels

� Flow of information

� Financial management

� UN coordination

Planning, Implementation and Management

Page 34: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� UNODC priority and comparative advantage

� Objectives: relevance and attainability

� Progress towards objectives and results

� Usefulness of results

� Likely impact

� Sustainability

� Problems and constraints

� Planning, implementation and management

� Role of UNODC

Findings

Page 35: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Overall positive

� Role of regional coordinator

� Relations with UNODC HQ

� Technical expertise

� Expanding role

Role of UNODC

Page 36: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Prison settings

� NGOs

� Demands of managing a small grants programme

� M&E framework

Lessons Learned

Page 37: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� General

� UNODC

� Estonia

� Latvia

� Lithuania

Recommendations

Page 38: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� General

� UNODC

� Estonia

� Latvia

� Lithuania

Recommendations

Page 39: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Maintain and strengthen focus on activities among IDUs and in prison settings

� Ensure the equivalence of the provision of health services in communities, arrest houses and in prison settings

� Build bridges between services

General

Page 40: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� General

� UNODC

� Estonia

� Latvia

� Lithuania

Recommendations

Page 41: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Rapidly adopt M&E framework

� Support organisational development of NGOs

� Make project coordination mechanisms more sustainable

� Introduce ‘sustainability assessments’ for small grants

� Retain flexible approach to financing

� Review management role

� Provide training on ethics for health professionals

� Mapping range and quality of services at LTCs

� Improve information flow

� Resolve issues of financial management with UNDP

� Consider adopting a ‘light’ joint UN team on AIDS

UNODC

Page 42: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Rapidly adopt M&E framework

� Support organisational development of NGOs

� Make project coordination mechanisms more sustainable

� Introduce ‘sustainability assessments’ for small grants

� Retain flexible approach to financing

� Review management role

� Provide training on ethics for health professionals

� Mapping range and quality of services at LTCs

� Improve information flow

� Resolve issues of financial management with UNDP

� Consider adopting a ‘light’ joint UN team on AIDS

UNODC

Page 43: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Funding Mechanisms

Level 4: In addition to levels 1-3, funding flows

through identified sustainable mechanism

Level 3: In addition to levels 1-2, sustainable funder is involved in project management and supervision

Level 2: In addition to level 1, sustainable funder

gives in-principle commitment to continue funding activities

Level 1: Sustainable source of future funding clearly

identified and agreed

Page 44: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Rapidly adopt M&E framework

� Support organisational development of NGOs

� Make project coordination mechanisms more sustainable

� Introduce ‘sustainability assessments’ for small grants

� Retain flexible approach to financing

� Review management role

� Provide training on ethics for health professionals

� Mapping range and quality of services at LTCs

� Improve information flow

� Resolve issues of financial management with UNDP

� Consider adopting a ‘light’ joint UN team on AIDS

UNODC

Page 45: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� General

� UNODC

� Estonia

� Latvia

� Lithuania

Recommendations

Page 46: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� National guidelines for MMT

� Study reasons for slow take-up of MMT in Tartu

Estonia

Page 47: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� General

� UNODC

� Estonia

� Latvia

� Lithuania

Recommendations

Page 48: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Establish task force for expansion of MMT

� Commit to pilot MMT in one prison

� Review provision of ART

� Adopt new AIDS programme

Latvia

Page 49: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� General

� UNODC

� Estonia

� Latvia

� Lithuania

Recommendations

Page 50: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

� Review and revise new national AIDS programmebased on ASAP comments

� Commit to piloting MMT in one prison

� Explore ways of financing ART in prison

Lithuania

Page 51: Findings of Mid-Term Evaluation...Presented by Roger Drew Riga 29 th January 2009 Findings of Mid-Term Evaluation HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

Presented by Roger Drew

Riga29th January 2009

Findings of Mid-Term Evaluation

HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG USERS AND IN PRISON

SETTINGS IN ESTONIA, LATVIA AND LITHUANIA